Hao Hong, Ph.D
Chairman & Chief Executive Officer of Asymchem Labs.
Dr. Hong established Asymchem in Research Triangle Park (RTP), North Carolina in 1995. Since its inception, Asymchem has grown to become a global player in the CRO/CMO pharmaceutical R&D and manufacturing world, with over 4,000 employees worldwide. Asymchem’s rapid early success inspired Dr. Hong to return to China in 1998 to invest, resulting in the creation of Asymchem Group, which is located in Tianjin Economic and Development Area (TEDA), Tianjin; Fuxin, Liaoning; and Dunhua, Jilin. Dr. Hong has actively directed and ensured the proper establishment and growth of all aspects of Asymchem, including R&D, QA, safety, technical, and business development. Today, Asymchem is one of the industry’s front-runners, garnering the respect and admiration of peers, clients, and field specialists alike. Asymchem, a listed company under the symbol “002821” in China, with its phenomenal growth over the past twenty years, is a testament to Dr. Hong's leadership skills, long-term vision, and perseverance.
Dr. Hong obtained his Ph.D. from the Chinese Academy of Medical Sciences in Beijing in 1987 and finished his post-doctorate training at the department of Pharmaceutical and Chemistry at the University of Georgia in 1989, garnering 58 patents and 18 high impact factor publications. He is a visiting professor at Sichuan University and an economic development consultant for the Dunhua municipality, as well as a co-chair of the TEDA Business Association.